Sponsor pipeline

Institut de Recherches Internationales Servier clinical trial pipeline

Get alerts when Institut de Recherches Internationales Servier's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-24

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    Primary completion pushed from Jul 23, 2026 to Sep 13, 2027

    Also in this update: Enrollment closed, study ongoing

    Institut de Recherches Internationales ServierPhase 1/2 NCT06501625 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
4
Phase 1/2
4
Phase 3
4

Disease areas by active trials, top 10 of 11

Leukemia (4) · Myelodysplastic Syndromes (MDS) (4) · Acute Myeloid Leukemia (AML) (3) · Glioma (3) · Colorectal Cancer (2) · Cholangiocarcinoma (1) · Epilepsy (1) · Head & Neck Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1)

Get alerts when Institut de Recherches Internationales Servier's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free